Blood Advances | 2019
Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1.
Ustun C, Kim S, Chen M, Beitinjaneh AM, Brown VI, Dahi PB, Daly A, Diaz MA, Freytes CO, Ganguly S, Hashmi S, Hildebrandt GC, Lazarus HM, Nishihori T, Olsson RF, Page KM, Papanicolaou G, Saad A, Seo S, William BM, Wingard JR, Wirk B, Yared JA, Perales M-A, Auletta JJ, Komanduri KV, Lindemans CA, Riches ML
PubMed
PMID: 31471322
Abstract
Related Articles
CIBMTR Study #: IN13-01